SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - FRA:SHL - DE000SHL1006 - Common Stock
49.53 EUR
+0.17 (+0.34%)
We assign a fundamental rating of 5 out of 10 to SHL. SHL was compared to 59 industry peers in the Health Care Equipment & Supplies industry. SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. SHL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
In the past year SHL had a positive cash flow from operations.
SHL had positive earnings in each of the past 5 years.
Each year in the past 5 years SHL had a positive operating cash flow.
1.2 Ratios
SHL's Return On Assets of 4.87% is fine compared to the rest of the industry. SHL outperforms 62.71% of its industry peers.
SHL has a Return On Equity of 12.29%. This is in the better half of the industry: SHL outperforms 74.58% of its industry peers.
SHL's Return On Invested Capital of 7.89% is fine compared to the rest of the industry. SHL outperforms 69.49% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SHL is below the industry average of 9.04%.
The 3 year average ROIC (5.87%) for SHL is below the current ROIC(7.89%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
With a decent Profit Margin value of 9.29%, SHL is doing good in the industry, outperforming 66.10% of the companies in the same industry.
SHL's Profit Margin has declined in the last couple of years.
SHL has a better Operating Margin (13.76%) than 62.71% of its industry peers.
In the last couple of years the Operating Margin of SHL has declined.
With a Gross Margin value of 38.76%, SHL is not doing good in the industry: 76.27% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
SHL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SHL has more shares outstanding
SHL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.13 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
SHL has a Altman-Z score (2.13) which is in line with its industry peers.
SHL has a debt to FCF ratio of 5.10. This is a neutral value as SHL would need 5.10 years to pay back of all of its debts.
SHL has a Debt to FCF ratio (5.10) which is in line with its industry peers.
A Debt/Equity ratio of 0.66 indicates that SHL is somewhat dependend on debt financing.
SHL has a worse Debt to Equity ratio (0.66) than 71.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.13 |
ROIC/WACC1.27
WACC6.22%
2.3 Liquidity
SHL has a Current Ratio of 1.12. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.12, SHL is doing worse than 69.49% of the companies in the same industry.
SHL has a Quick Ratio of 1.12. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
SHL has a worse Quick ratio (0.77) than 71.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.21% over the past year.
SHL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.27% yearly.
The Revenue has been growing slightly by 5.85% in the past year.
SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
Based on estimates for the next years, SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.71% on average per year.
Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.62% on average per year.
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.81, SHL is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 76.27% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SHL to the average of the S&P500 Index (26.91), we can say SHL is valued slightly cheaper.
With a Price/Forward Earnings ratio of 18.95, SHL is valued on the expensive side.
66.10% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.92, SHL is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.81 | ||
| Fwd PE | 18.95 |
4.2 Price Multiples
SHL's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 84.75% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.16 | ||
| EV/EBITDA | 15.11 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHL does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)2.15
PEG (5Y)2.86
EPS Next 2Y8.26%
EPS Next 3Y9.53%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.00%.
Compared to an average industry Dividend Yield of 2.36, SHL pays a bit more dividend than its industry peers.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
5.2 History
On average, the dividend of SHL grows each year by 6.35%, which is quite nice.
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.08% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.08%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
FRA:SHL (10/24/2025, 7:00:00 PM)
49.53
+0.17 (+0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap55.87B
Revenue(TTM)23.38B
Net Income(TTM)2.17B
Analysts83.7
Price Target61.88 (24.93%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0%
PT rev (3m)-0.53%
EPS NQ rev (1m)-0.24%
EPS NQ rev (3m)-8.5%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-2.25%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-1.03%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.81 | ||
| Fwd PE | 18.95 | ||
| P/S | 2.39 | ||
| P/FCF | 18.16 | ||
| P/OCF | 14.53 | ||
| P/B | 3.16 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.11 |
EPS(TTM)2.38
EY4.81%
EPS(NY)2.61
Fwd EY5.28%
FCF(TTM)2.73
FCFY5.51%
OCF(TTM)3.41
OCFY6.88%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)2.15
PEG (5Y)2.86
Graham Number28.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexgc growth 3Y-8.79%
ROICexgc growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 2.13 |
F-Score8
WACC6.22%
ROIC/WACC1.27
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.68%
EPS Next 2Y8.26%
EPS Next 3Y9.53%
EPS Next 5Y9.71%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.89%
Revenue Next 2Y4.63%
Revenue Next 3Y5.08%
Revenue Next 5Y5.62%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.21%
EBIT Next 3Y20.47%
EBIT Next 5Y15.42%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 20.81 and the Price/Book (PB) ratio is 3.16.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.08%.